Clinical trial
GSK BHR Study (Sont - Second Study)
NCT01324362
Study timeline
Study start (unknown)2003-01-01Date precision: month
Registry last updated2016-09-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
PlaceboDRUG
PlaceboDRUG
FP 100mcgDRUG
FP 250mcgDRUG
FP 500mcgDRUG
FSC 100/50mcgDRUG
FSC 250/50mcgDRUG
FSC500/50mcgDRUG
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
Los AngelesCalifornia, United States3DallasTexas, United States2TampaFlorida, United States2OmahaNebraska, United States2HoustonTexas, United States1BaltimoreMaryland, United States1SeattleWashington, United States1ClevelandOhio, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1JacksonvilleFlorida, United States1DenverColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01324362 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.